Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Escitalopram

CompanyA-S Medication Solutions (DUNS: 830016429)

Effective Date

March 7, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Escitalopram(20 mg in 1 1)

Manufacturing Establishments (1)

A-S Medication Solutions

Labeler

A-S Medication Solutions

DUNS Number

830016429

Products (1)

Escitalopram

NDC Product Code

50090-5830

Application Number

ANDA078169

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

March 1, 2022

Ingredients

HYPROMELLOSE 2910 (5 MPA.S)Inactive

Code: R75537T0T4Class: IACT

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

TITANIUM DIOXIDEInactive

Code: 15FIX9V2JPClass: IACT

CROSCARMELLOSE SODIUMInactive

Code: M28OL1HH48Class: IACT

EscitalopramActive

Code: 5U85DBW7LOClass: ACTIMQuantity: 20 mg in 1 1

POLYETHYLENE GLYCOL 400Inactive

Code: B697894SGQClass: IACT

TALCInactive

Code: 7SEV7J4R1UClass: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy